Does OSIMERTINIB Cause Haemoglobin decreased? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Haemoglobin decreased have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.2% of all adverse event reports for OSIMERTINIB.
56
Reports of Haemoglobin decreased with OSIMERTINIB
0.2%
of all OSIMERTINIB reports
11
Deaths
26
Hospitalizations
How Dangerous Is Haemoglobin decreased From OSIMERTINIB?
Of the 56 reports, 11 (19.6%) resulted in death, 26 (46.4%) required hospitalization, and 6 (10.7%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which OSIMERTINIB Alternatives Have Lower Haemoglobin decreased Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN